Extended Administration of Polyethylene Glycol (PEG) Interferon Alfa-2b in Participants With Solid Tumors (C/I97-349/MK-4031-009)
Clinical trial NCT03554005 · COMPLETED
Trial details
- NCT number
- NCT03554005
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 1997-12-29
- Primary completion
- 2001-03-16
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.